Coronavirus vaccine mandate ‘tidal wave is coming’ after Pfizer FDA approval
CEID Faculty Dr. David Hamer shares his reaction to the Pfizer-BioNTech COVID-19 vaccine approval in the Boston Herald.
Local Reaction To Pfizer Vaccine FDA Approval
CEID Faculty Dr. David Hamer discusses his reaction to the full FDA approval of the Pfizer-BioNTech COVID-19 vaccine.
The US Is Getting Covid Booster Shots. The World Is Furious
CEID Faculty Dr. Ellie Murray joins WIRED to explain the need for ensuring global vaccine equity and that vaccines are administered to those who need them most.
The U.S. Is Getting a Crash Course in Scientific Uncertainty
CEID Faculty members Dr. Eleanor Murray & Dr. Syra Madad explain the reasons behind the uncertainty that we are facing during the COVID-19 pandemic.
Biden Plan Prods Scientists to Back Boosters Despite Murky Data
CEID Faculty Dr. Eleanor Murray is skeptical for the need for boosters and provides evidence to explain her position.
Transcript: The Last Word with Lawrence O’Donnell, 8/20/21
CEID Founding Director Dr. Nahid Bhadelia offers her predictions on what will happen next after the FDA approval of the Pfizer/BioNTech COVID-19 vaccine.
Massachusetts infectious disease doctors say COVID-19 booster plan is too broad
CEID Founding Director Dr. Nahid Bhadelia & CEID Faculty Syra Madad offers their reactions to the recent announcement from the CDC about COVID-19 booster shots.
How health experts are navigating daily life amid the delta variant surge
CEID Founding Director Dr. Nahid Bhadelia shares how she would navigate the risk of contracting or spreading COVID-19 given the delta variant.
As U.S. promotes booster shots against Covid, moral questions arise over vaccine equity
CEID Faculty Dr. Ellie Murray discusses the data we have on breakthrough infections and how we should act to ensure global vaccine equity.
Boston Infectious Disease Doctor Says Booster Shot Plan Brings Up Complicated Issues
CEID Founding Director Dr. Nahid Bhadelia discusses the data we have on COVID-19 booster shots and the larger discussion of ensuring global vaccine equity.